Terms: = Breast cancer AND SUZ12, CHET9, 23512, ENSG00000178691, Q15022, KIAA0160, JJAZ1
41 results:
1. ESR1 hotspot mutations in endometrial stromal sarcoma with high-grade transformation and endocrine treatment.
Dessources K; Miller KM; Kertowidjojo E; Da Cruz Paula A; Zou Y; Selenica P; da Silva EM; Benayed R; Ashley CW; Abu-Rustum NR; Dogan S; Soslow RA; Hensley ML; Weigelt B; Chiang S
Mod Pathol; 2022 Jul; 35(7):972-978. PubMed ID: 34961764
[TBL] [Abstract] [Full Text] [Related]
2. Decreased PRC2 activity supports the survival of basal-like breast cancer cells to cytotoxic treatments.
Mieczkowska IK; Pantelaiou-Prokaki G; Prokakis E; Schmidt GE; Müller-Kirschbaum LC; Werner M; Sen M; Velychko T; Jannasch K; Dullin C; Napp J; Pantel K; Wikman H; Wiese M; Kramm CM; Alves F; Wegwitz F
Cell Death Dis; 2021 Nov; 12(12):1118. PubMed ID: 34845197
[TBL] [Abstract] [Full Text] [Related]
3. PRMT1-mediated EZH2 methylation promotes breast cancer cell proliferation and tumorigenesis.
Li Z; Wang D; Chen X; Wang W; Wang P; Hou P; Li M; Chu S; Qiao S; Zheng J; Bai J
Cell Death Dis; 2021 Nov; 12(11):1080. PubMed ID: 34775498
[TBL] [Abstract] [Full Text] [Related]
4. ER-/PR+ breast cancer: A distinct entity, which is morphologically and molecularly close to triple-negative breast cancer.
Beltjens F; Molly D; Bertaut A; Richard C; Desmoulins I; Loustalot C; Charon-Barra C; Courcet E; Bergeron A; Ladoire S; Jankowski C; Boidot R; Arnould L
Int J Cancer; 2021 Jul; 149(1):200-213. PubMed ID: 33634878
[TBL] [Abstract] [Full Text] [Related]
5. Interplay between desmoglein2 and hypoxia controls metastasis in breast cancer.
Chang PH; Chen MC; Tsai YP; Tan GYT; Hsu PH; Jeng YM; Tsai YF; Yang MH; Hwang-Verslues WW
Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33431674
[TBL] [Abstract] [Full Text] [Related]
6. Structural assembly of Polycomb group protein and Insight of EZH2 in cancer progression: A review.
Gautam N; Kaur M; Kaur S
J Cancer Res Ther; 2021; 17(2):311-326. PubMed ID: 33063698
[TBL] [Abstract] [Full Text] [Related]
7. Genomic Profiling Aids Classification of Diagnostically Challenging Uterine Mesenchymal Tumors With Myomelanocytic Differentiation.
Selenica P; Conlon N; Gonzalez C; Frosina D; Jungbluth AA; Beets-Tan RGH; Rao MK; Zhang Y; Benayed R; Ladanyi M; Solit DB; Chiang S; Hyman DM; Hensley ML; Soslow RA; Weigelt B; Murali R
Am J Surg Pathol; 2021 Jan; 45(1):77-92. PubMed ID: 32889887
[TBL] [Abstract] [Full Text] [Related]
8. Stochastic Epigenetic Mutations Are Associated with Risk of breast cancer, Lung cancer, and Mature B-cell Neoplasms.
Gagliardi A; Dugué PA; Nøst TH; Southey MC; Buchanan DD; Schmidt DF; Makalic E; Hodge AM; English DR; Doo NW; Hopper JL; Severi G; Baglietto L; Naccarati A; Tarallo S; Pace L; Krogh V; Palli D; Panico S; Sacerdote C; Tumino R; Lund E; Giles GG; Pardini B; Sandanger TM; Milne RL; Vineis P; Polidoro S; Fiorito G
Cancer Epidemiol Biomarkers Prev; 2020 Oct; 29(10):2026-2037. PubMed ID: 32788174
[TBL] [Abstract] [Full Text] [Related]
9. Relevance and clinicopathologic relationship of BRAF V600E, TERT and NRAS mutations for papillary thyroid carcinoma patients in Northwest China.
Huang M; Yan C; Xiao J; Wang T; Ling R
Diagn Pathol; 2019 Jul; 14(1):74. PubMed ID: 31300059
[TBL] [Abstract] [Full Text] [Related]
10. An ErbB2/c-Src axis links bioenergetics with PRC2 translation to drive epigenetic reprogramming and mammary tumorigenesis.
Smith HW; Hirukawa A; Sanguin-Gendreau V; Nandi I; Dufour CR; Zuo D; Tandoc K; Leibovitch M; Singh S; Rennhack JP; Swiatnicki M; Lavoie C; Papavasiliou V; Temps C; Carragher NO; Unciti-Broceta A; Savage P; Basik M; van Hoef V; Larsson O; Cooper CL; Vargas Calderon AC; Beith J; Millar E; Selinger C; Giguère V; Park M; Harris LN; Varadan V; Andrechek ER; O'Toole SA; Topisirovic I; Muller WJ
Nat Commun; 2019 Jul; 10(1):2901. PubMed ID: 31263101
[TBL] [Abstract] [Full Text] [Related]
11. TBX2 interacts with heterochromatin protein 1 to recruit a novel repression complex to EGR1-targeted promoters to drive the proliferation of breast cancer cells.
Crawford NT; McIntyre AJ; McCormick A; D'Costa ZC; Buckley NE; Mullan PB
Oncogene; 2019 Aug; 38(31):5971-5986. PubMed ID: 31253870
[TBL] [Abstract] [Full Text] [Related]
12. Role of p38γ MAPK in regulation of EMT and cancer stem cells.
Xu M; Wang S; Wang Y; Wu H; Frank JA; Zhang Z; Luo J
Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3605-3617. PubMed ID: 30251680
[TBL] [Abstract] [Full Text] [Related]
13. A double-negative feedback loop between DEAD-box protein DDX21 and Snail regulates epithelial-mesenchymal transition and metastasis in breast cancer.
Zhang H; Zhang Y; Chen C; Zhu X; Zhang C; Xia Y; Zhao Y; Andrisani OM; Kong L
Cancer Lett; 2018 Nov; 437():67-78. PubMed ID: 30165191
[TBL] [Abstract] [Full Text] [Related]
14. Extraskeletal osteosarcoma: MDM2 and H3K27me3 analysis of 19 cases suggest disease heterogeneity.
Makise N; Sekimizu M; Kubo T; Wakai S; Watanabe SI; Kato T; Kinoshita T; Hiraoka N; Fukayama M; Kawai A; Ichikawa H; Yoshida A
Histopathology; 2018 Jul; 73(1):147-156. PubMed ID: 29489027
[TBL] [Abstract] [Full Text] [Related]
15. Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function.
Wan L; Xu K; Wei Y; Zhang J; Han T; Fry C; Zhang Z; Wang YV; Huang L; Yuan M; Xia W; Chang WC; Huang WC; Liu CL; Chang YC; Liu J; Wu Y; Jin VX; Dai X; Guo J; Liu J; Jiang S; Li J; Asara JM; Brown M; Hung MC; Wei W
Mol Cell; 2018 Jan; 69(2):279-291.e5. PubMed ID: 29351847
[TBL] [Abstract] [Full Text] [Related]
16. HIFI-α activation underlies a functional switch in the paradoxical role of Ezh2/PRC2 in breast cancer.
Mahara S; Lee PL; Feng M; Tergaonkar V; Chng WJ; Yu Q
Proc Natl Acad Sci U S A; 2016 Jun; 113(26):E3735-44. PubMed ID: 27303043
[TBL] [Abstract] [Full Text] [Related]
17. Expression of ANRIL-Polycomb Complexes-CDKN2A/B/ARF Genes in breast Tumors: Identification of a Two-Gene (EZH2/CBX7) Signature with Independent Prognostic Value.
Meseure D; Vacher S; Alsibai KD; Nicolas A; Chemlali W; Caly M; Lidereau R; Pasmant E; Callens C; Bieche I
Mol Cancer Res; 2016 Jul; 14(7):623-33. PubMed ID: 27102007
[TBL] [Abstract] [Full Text] [Related]
18. PRC2 regulates RNA polymerase III transcribed non-translated RNA gene transcription through EZH2 and suz12 interaction with TFIIIC complex.
Liu C; Li S; Dai X; Ma J; Wan J; Jiang H; Wang P; Liu Z; Zhang H
Nucleic Acids Res; 2015 Jul; 43(13):6270-84. PubMed ID: 26038315
[TBL] [Abstract] [Full Text] [Related]
19. Analysis of interactions between the epigenome and structural mutability of the genome using Genboree Workbench tools.
Coarfa C; Pichot C; Jackson A; Tandon A; Amin V; Raghuraman S; Paithankar S; Lee AV; McGuire SE; Milosavljevic A
BMC Bioinformatics; 2014; 15 Suppl 7(Suppl 7):S2. PubMed ID: 25080362
[TBL] [Abstract] [Full Text] [Related]
20. ERG induces a mesenchymal-like state associated with chemoresistance in leukemia cells.
Mochmann LH; Neumann M; von der Heide EK; Nowak V; Kühl AA; Ortiz-Tanchez J; Bock J; Hofmann WK; Baldus CD
Oncotarget; 2014 Jan; 5(2):351-62. PubMed ID: 24504051
[TBL] [Abstract] [Full Text] [Related]
[Next]
